National Health Investors, Inc. (NYSE:NHI) insider Kevin Carlton Pascoe sold 2,000 shares of the firm’s stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $79.80, for a total transaction of $159,600.00. Following the sale, the insider now owns 21,228 shares of the company’s stock, valued at $1,693,994.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Shares of National Health Investors, Inc. (NHI) opened at 79.61 on Thursday. The firm’s 50 day moving average is $77.39 and its 200-day moving average is $75.39. National Health Investors, Inc. has a 12 month low of $66.31 and a 12 month high of $82.53. The firm has a market capitalization of $3.26 billion, a PE ratio of 20.44 and a beta of 0.56.

National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.93 EPS for the quarter, missing analysts’ consensus estimates of $1.29 by $0.36. The business had revenue of $69.84 million during the quarter, compared to analyst estimates of $67.68 million. National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. National Health Investors’s revenue for the quarter was up 14.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.22 EPS. On average, analysts expect that National Health Investors, Inc. will post $3.88 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 10th. Shareholders of record on Friday, September 29th will be paid a $0.95 dividend. This represents a $3.80 dividend on an annualized basis and a yield of 4.77%. The ex-dividend date is Thursday, September 28th. National Health Investors’s dividend payout ratio is currently 97.69%.

ILLEGAL ACTIVITY NOTICE: This piece was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/31/national-health-investors-inc-nhi-insider-sells-159600-00-in-stock.html.

Several equities research analysts recently issued reports on the stock. Zacks Investment Research cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Thursday. BidaskClub upgraded shares of National Health Investors from a “sell” rating to a “hold” rating in a research report on Thursday, August 17th. Mizuho restated a “neutral” rating on shares of National Health Investors in a research report on Wednesday, June 28th. Stifel Nicolaus raised their price objective on shares of National Health Investors from $80.00 to $82.00 and gave the stock a “buy” rating in a research report on Wednesday, June 21st. Finally, ValuEngine cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, June 13th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and two have given a buy rating to the company. National Health Investors has a consensus rating of “Hold” and an average price target of $81.20.

A number of institutional investors have recently bought and sold shares of the company. Schwab Charles Investment Management Inc. raised its position in National Health Investors by 9.7% in the first quarter. Schwab Charles Investment Management Inc. now owns 161,309 shares of the real estate investment trust’s stock worth $11,716,000 after buying an additional 14,297 shares in the last quarter. BlackRock Inc. raised its position in National Health Investors by 6,473.4% in the first quarter. BlackRock Inc. now owns 3,328,567 shares of the real estate investment trust’s stock worth $241,753,000 after buying an additional 3,277,930 shares in the last quarter. Bank of America Corp DE raised its position in National Health Investors by 2.5% in the first quarter. Bank of America Corp DE now owns 388,780 shares of the real estate investment trust’s stock worth $28,238,000 after buying an additional 9,538 shares in the last quarter. Daiwa Securities Group Inc. raised its position in National Health Investors by 1.7% in the first quarter. Daiwa Securities Group Inc. now owns 3,200 shares of the real estate investment trust’s stock worth $232,000 after buying an additional 55 shares in the last quarter. Finally, Adams Diversified Equity Fund Inc. raised its position in National Health Investors by 3.0% in the first quarter. Adams Diversified Equity Fund Inc. now owns 13,700 shares of the real estate investment trust’s stock worth $995,000 after buying an additional 400 shares in the last quarter. 70.58% of the stock is currently owned by institutional investors.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Receive News & Stock Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related stocks with our FREE daily email newsletter.